Strides Arcolab receives USFDA approval for Methoxsalen Softgel Capsules

06 Jun 2014 Evaluate

Strides Arcolab has received approval from the United States Food & Drug Administration (USFDA) for Methoxsalen Capsules USP, 10 mg (Soft Gelatin Capsules). According to IMS data, the US market for generic Methoxsalen Capsule is approximately $13.6 Million, with no generic player. The product will be manufactured at the Company's USFDA approved Oral dosage facility at Bangalore and marketed directly by Strides in the US Market.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

793.60 -2.60 (-0.33%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×